73 material Form 8-K filings that 66 companies we cover made with the SEC in January 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Vericel said in a January 9, 2024 press release and updated investor presentation that full-year 2023 total net revenue is expected to be about $197.5 million, up 20%, with fourth-quarter revenue of about $65.0 million, up 23%. The figures are preliminary and unaudited, and the company warned that final results may differ materially. The company also reported about $152 million in cash, restricted cash and investments and no debt as of December 31, 2023.
Full-year 2023 MACI net revenue expected at about $164.8 million, up 25%; Burn Care about $32.7 million
Fourth-quarter 2023 total net revenue expected at about $65.0 million, up 23%; gross margin expected above 70%
Full-year 2023 adjusted EBITDA margin expected in the mid-teens percentage range, with adjusted EBITDA growth of about 30%
Results are preliminary and unaudited; the company's J.P. Morgan presentation is scheduled for January 10, 2024
PriceSmart reported first quarter fiscal 2024 results for the quarter ended November 30, 2023, with total revenues up 10.6% to $1.17 billion and net income up 15.5% to $38.0 million, or $1.24 per diluted share, versus $1.05 a year earlier. The results show growth in both sales and profit, though part of the sales gain came from favorable currency effects; the filing contains no guidance.
Total revenues rose 10.6% to $1.17 billion; net merchandise sales rose 10.7% to $1.14 billion
Net merchandise sales grew 6.8% on a constant-currency basis; currency added 3.9 percentage points
Net income was $38.0 million, or $1.24 per diluted share, versus $32.9 million, or $1.05, a year earlier
Adjusted EBITDA was $77.8 million versus $75.2 million; the company will host a conference call on January 10, 2024 at 12:00 p.m. Eastern time
Glaukos said preliminary, unaudited net sales were expected to exceed $81 million for the fourth quarter and $313 million for fiscal 2023, compared with $283 million for 2022 as shown in its investor presentation. The company also reaffirmed its 2024 net sales guidance of $350 million to $360 million, so shareholders have a preliminary sales figure ahead of audited results and no change to the outlook.
Preliminary fourth-quarter 2023 net sales expected to be in excess of $81 million
Preliminary full-year 2023 net sales expected to be in excess of $313 million, versus $283 million in 2022 per the investor presentation
2024 net sales guidance reaffirmed at $350 million to $360 million
Figures are preliminary and unaudited, per the press release dated January 9, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.